The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Acceleron Pharma, Inc. Common 00434H108 2,704 105,964 SH   SOLE   105,964 0 0
Atara Biotherapeutics, Inc. Common 046513107 150 10,543 SH   SOLE   10,543 0 0
Box, Inc. Common 10316T104 3,692 266,399 SH   SOLE   266,399 0 0
CytomX Therpeutics, Inc. Common 23284F105 110 10,000 SH   SOLE   10,000 0 0
Editas Medicine Common 28106W103 590 36,362 SH   SOLE   36,362 0 0
Global Blood Therapeutics, Inc. Common 37890U108 1,358 93,960 SH   SOLE   93,960 0 0
LendingClub Corp. Common 52603A109 9,976 1,900,206 SH   SOLE   1,900,206 0 0
MyoKardia, Inc. Common 62857M105 572 44,145 SH   SOLE   44,145 0 0
Sage Therapeutics, Inc. Common 78667J108 1,183 23,168 SH   SOLE   23,168 0 0
Silver Springs Network, Inc. Common 82817Q103 137 10,320 SH   SOLE   10,320 0 0
Tesla, Inc. Common 88160R101 678 3,175 SH   SOLE   3,175 0 0
Trevena, Inc. Common 89532E109 1,833 311,650 SH   SOLE   311,650 0 0
Voyager Therapeutics, Inc. Common 92915B106 463 36,362 SH   SOLE   36,362 0 0
Finjan Holdings, Inc. Common 31788H303 4,875 4,303,435 SH   SOLE   4,303,435 0 0
Wayfair, Inc. Common 94419L101 135,311 3,860,511 SH   SOLE   3,860,511 0 0
YUMA Energy, Inc. Common 98872F105 1,918 564,086 SH   SOLE   564,086 0 0